Raily Aesthetic Medicine International Holdings Limited
HKEX:2135.HK
0.096 (HKD) • At close January 15, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) HKD.
| 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q2 | 2021 Q4 | 2021 Q2 | |
|---|---|---|---|---|---|---|---|---|
| Revenue
| 89.814 | 45.902 | 101.962 | 48.79 | 69.094 | 97.279 | 95.677 | 91.354 |
| Cost of Revenue
| 58.054 | 29.67 | 61.18 | 29.276 | 47.015 | 51.549 | 63.484 | 54.314 |
| Gross Profit
| 31.76 | 16.232 | 40.782 | 19.515 | 22.078 | 45.73 | 32.193 | 37.04 |
| Gross Profit Ratio
| 0.354 | 0.354 | 0.4 | 0.4 | 0.32 | 0.47 | 0.336 | 0.405 |
| Reseach & Development Expenses
| 1.567 | 0.801 | 0 | 0 | 1.971 | 0 | 0 | 0 |
| General & Administrative Expenses
| 10.781 | 10.781 | 0 | 9.27 | 0 | 0 | 0 | 0 |
| Selling & Marketing Expenses
| 14.76 | 14.76 | 0 | 11.383 | 0 | 0 | 0 | 0 |
| SG&A
| 49.659 | 25.541 | 43.741 | 20.652 | 41.714 | 44.14 | 46.843 | 41.765 |
| Other Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses
| 51.226 | 32.013 | 43.741 | 20.258 | 43.685 | 44.14 | 46.843 | 41.765 |
| Operating Income
| -19.466 | -10.11 | -2.959 | -1.138 | -21.606 | 1.59 | -14.65 | -4.725 |
| Operating Income Ratio
| -0.217 | -0.22 | -0.029 | -0.023 | -0.313 | 0.016 | -0.153 | -0.052 |
| Total Other Income Expenses Net
| -10.427 | -5.998 | 0.122 | -0.261 | -2.113 | 0.611 | -2.384 | -0.816 |
| Income Before Tax
| -29.893 | -16.107 | -2.837 | -1.398 | -23.72 | 2.201 | -17.034 | -5.541 |
| Income Before Tax Ratio
| -0.333 | -0.351 | -0.028 | -0.029 | -0.343 | 0.023 | -0.178 | -0.061 |
| Income Tax Expense
| 1.437 | 0.735 | 1.358 | 0.65 | -3.697 | 1.956 | -4.515 | -0.11 |
| Net Income
| -29.547 | -15.101 | -2.356 | -1.128 | -17.137 | 1.527 | -12.3 | -5.229 |
| Net Income Ratio
| -0.329 | -0.329 | -0.023 | -0.023 | -0.248 | 0.016 | -0.129 | -0.057 |
| EPS
| -0.068 | -0.036 | -0.005 | -0.003 | -0.036 | 0.003 | -0.026 | -0.011 |
| EPS Diluted
| -0.068 | -0.036 | -0.005 | -0.003 | -0.036 | 0.003 | -0.026 | -0.011 |
| EBITDA
| -6.318 | -6.291 | 10.356 | 2.793 | -9.547 | 12.879 | -6.912 | 1.959 |
| EBITDA Ratio
| -0.07 | -0.137 | 0.102 | 0.057 | -0.138 | 0.132 | -0.072 | 0.021 |